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Polybrominated diphenyl ethers (PBDEs) 
are a class of flame retardants used in fur-
niture, carpeting, textiles, electronics, and 
plastics to reduce the risk of ignition and slow 
down burning rates. Because PBDEs are not 
covalently bound to these materials, they 
may leach into the surrounding environment. 
PBDEs have been globally detected in soil 
(Agency for Toxic Substances and Disease 
Registry 2004), sediment (Hites 2004), food 
(Branchi et al. 2003; Hites 2004), and air 
(Hites 2004). Measures of PBDEs in house 
dust indicate widespread contamination in 
homes (Jones-Otazo et al. 2005; Wilford et al. 
2004), and house dust may be an important 
human exposure pathway (Lorber 2008).
Studies indicate near universal exposure 
to PBDEs among the general population, 
with 97% of American adults sampled in the 
nationally representative National Health and 
Nutrition Examination Survey (NHANES) 
having detectable PBDE levels in their blood 
(Sjödin et al. 2008). In North America, con-
centrations in humans have been doubling 
every 4–6 years since the 1970s (Hites 2004). 
Levels of PBDEs are approximately 20 times 
higher in populations in the United States than 
in Europe (Hites 2004; Wilford et al. 2004; 
Zuurbier et al. 2006), with California residents 
experiencing the highest exposures (Fischer 
et al. 2006; Petreas et al. 2003; She et al. 2002; 
Zota et al. 2008), possibly due to the state’s 
strict flammability standards legislation.
Three technical PBDE mixtures have been 
commercially produced. Known as penta-, 
octa-, and deca-BDE, they are designated by 
their average degree of bromination (Alaee 
et al. 2003). Penta-BDE consists mainly of 
PBDE congeners with four to six bromines 
(e.g., BDE-47 and BDE-99), octa-BDE con-
tains congeners with 6–10 bromines (includ-
ing BDE-153), and deca-BDE consists almost 
exclusively of BDE-209 (La Guardia et al. 
2006). Although penta- and octa-BDE have 
been banned for use in the United States, 
exposure continues because these mixtures 
are present in furniture and other home prod-
ucts manufactured before 2004. Deca-BDE 
continues to be used, primarily in electronic 
products. The congeners found in the greatest 
concentration in human serum in the U.S. 
general population are BDEs 47, 99, 100, 
and 153, which are the primary components 
of penta-BDE (Sjödin et al. 2008). However, 
few studies have been able to measure BDE-
209 in serum.
In animal studies, PBDEs have been 
shown to affect neurobehavior (Branchi et al. 
2002; Dufault et al. 2005; Eriksson et al. 2001, 
2002; Johansson et al. 2008; Viberg et al. 
2003a, 2003b, 2004, 2006) and to alter sex 
hormone and thyroid hormone homeostasis 
(Ellis-Hutchings et al. 2006; Fowles et al. 
1994; Hallgren and Darnerud 2002; Hallgren 
et al. 2001; Stoker et al. 2004; Zhou et al. 
2001, 2002), but few studies have investigated 
potential health effects in humans. Thyroid 
hormones play a strong role in the regulation 
of ovulation, menstrual cycle regularity, and 
fertility (Krassas 2000; Poppe and Velkeniers 
2004). PBDEs, which exhibit estrogenic and 
antiestrogenic properties, have also been associ-
ated with delayed onset of puberty (Lilienthal 
et al. 2006; Stoker et al. 2004) and altered 
circulating levels of estradiol (Talsness et al. 
2008) in female animals.
Only one small human study (n = 20) has 
examined the association of PBDEs and female 
reproductive function. Chao et al.(2007) 
reported that higher PBDE levels in breast 
milk of new mothers were associated with 
shorter prepregnancy menstrual cycle length 
(< 30 days), but this finding was not statisti-
cally significant when models were adjusted 
for maternal age, body mass index, and parity. 
Our study of pregnant women in California is 
the first to examine the association of PBDE 
concentration in blood with time to pregnancy 
in humans.
Methods
Study participants. Participants were preg-
nant women enrolled in the Center for the 
Health Assessment of Mothers and Children 
of Salinas (CHAMACOS) study, a longitudi-
nal birth cohort study of environmental expo-
sures and reproductive health in the Salinas 
Valley, an agricultural region of California. 
Pregnant women were recruited from six 
prenatal care clinics serving a low-income, 
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Ba c k g r o u n d: Exposure to polybrominated diphenyl ether (PBDE) flame retardants is widespread, 
with 97% of Americans having detectable levels. Although PBDEs have been associated with repro-
ductive and hormonal effects in animals, no human studies have examined their association with 
fertility.
oBjectives: This study was designed to determine whether maternal concentrations of PBDEs 
in serum collected during pregnancy are associated with time to pregnancy and menstrual cycle 
characteristics.
Me t h o d s : Pregnant women (n = 223) living in a low-income, predominantly Mexican-immigrant 
community in California were interviewed to determine how many months they took to become preg-
nant. Blood samples were collected and analyzed for PBDEs. PBDE concentrations were lipid adjusted 
and log10 transformed. Analyses were limited to PBDE congeners detected in > 75% of the population 
(BDEs 47, 99, 100, 153). Cox proportional hazards models modified for discrete time were used to 
obtain fecundability odds ratios (fORs) for the association of PBDEs and time to pregnancy.
re s u l t s: We detected all four congeners in > 97% of women. Increasing levels of BDEs 47, 99, 
100, 153 and the sum of these four congeners were all associated with longer time to pregnancy. 
We observed significantly reduced fORs for BDE-100 [adjusted fOR = 0.6; 95% confidence 
interval (CI), 0.4–0.9], BDE-153 (adjusted fOR = 0.5; 95% CI, 0.3–0.8), and the sum of the four 
congeners (adjusted fOR = 0.7; 95% CI, 0.5–1.0). PBDEs were not associated with menstrual cycle 
characteristics.
co n c l u s i o n s: We found significant decreases in fecundability associated with PBDE exposure in 
women. Future studies are needed to replicate and confirm this finding.
key w o r d s : fecundability, flame retardants, menstrual cycle characteristics, PBDEs, time to 
pregnancy. Environ Health Perspect 118:699–704 (2010).  doi:10.1289/ehp.0901450 [Online 
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predominantly Mexican-immigrant popu-
lation. Women were eligible to participate 
if they were < 20 weeks gestation at enroll-
ment, spoke English or Spanish, were eligible 
for low-income health insurance (Medicaid), 
and were ≥ 18 years of age. All women pro-
vided written informed consent, and study 
procedures were approved by the Committee 
for the Protection of Human Subjects at the 
University of California–Berkeley.
A total of 601 pregnant women enrolled 
in the study, and of these, 343 women 
had PBDEs measured in serum collected 
during pregnancy. (The main reason for miss-
ing PBDE measurement was insufficient vol-
ume of serum remaining after other, higher 
priority toxicants were measured.) Women 
with PBDE measurements did not differ sig-
nificantly from those without PBDE measure-
ments on any of the main demographic or 
fertility-related variables listed in Table 1 (data 
not shown). The PBDE results for 24 women 
were excluded because of problems with the 
automated equipment used to process samples 
in that batch. We also excluded one woman 
who was missing time-to-pregnancy data, one 
woman using fertility medication during the 
month of conception, and 94 women using 
contraception at the time of conception (con-
traceptive failures), leaving a final sample of 
223 women who contributed 984 cycles to 
the analysis. In subsequent sensitivity analy-
ses, the 94 contraceptive users were included 
in the sample, increasing the sample size to 
317 women and 1,120 cycles.
Data collection. In-person interviews were 
conducted at the time of enrollment [median, 
13 weeks gestation; interquartile range (IQR), 
10–18 weeks]. The beginning of the pregnancy 
was determined by asking the woman the date 
of her last menstrual period (LMP) or, if she 
did not know (4%), by using the LMP esti-
mate from the clinical ultrasound. Women 
were then asked, “How many months did it 
take to become pregnant? In other words, for 
how many months had you been having sexual 
intercourse without doing anything to prevent 
pregnancy?” A calendar was used to help with 
recall. The interval between stopping contra-
ception and becoming pregnant was consid-
ered the “time-to-pregnancy period” and was 
marked on the calendar to aid recall about 
exposures during that time period.
Women were also asked whether they 
had had regular menstrual periods in the year 
before the pregnancy and, if so, how many 
days were in her cycle. Additional questions 
asked about hormonal contraceptive use in the 
year before the pregnancy, frequency of inter-
course, use of fertility medication, use of con-
traception (either regularly or inconsistently) 
during the month of conception, and whether 
she had been actively trying to get pregnant.
Information was also gathered about 
potential confounders, including maternal 
and paternal age, education, country of birth, 
and years of residence in the United States. 
Women were asked about their reproduc-
tive history, including prior pregnancies and 
breast-feeding history. Histories of gyneco-
logic conditions, urogenital surgeries, or sex-
ually transmitted infections were combined 
into a single variable indicating a history of 
relevant medical conditions. Body mass index 
was calculated from the mother’s measured 
height and self-reported prepregnancy weight. 
Information was also gathered on other expo-
sures that might affect fertility, including 
smoking and alcohol and caffeine consump-
tion in the time before conception. Because 
this is an agricultural population, we also gath-
ered information on maternal and paternal 
work in agriculture, pesticide use in the home, 
and residence near agricultural fields during 
the time-to-pregnancy period.
PBDE exposure. Maternal blood was col-
lected near the end of the second trimester 
of pregnancy (median, 26 weeks gestation; 
IQR, 25–27 weeks). PBDE concentrations 
in maternal serum were determined using 
Table 1. Selected characteristics of study population and their association with time to pregnancy: 
CHAMACOS study, 1999–2000 (n = 223).
Characteristic n (%)
Time to pregnancy 
[months, median (IQR)]
Maternal agea (years), all participants [median (IQR)] 23.9 (21.5–27.3) 3 (1–7)
Race/ethnicity
Non-Hispanic white 5 (2.2) 4 (4–15)
Hispanic 214 (96.0) 3 (1–7)
Other 4 (1.8) 2 (1–21)
Years of residence in the USA
≤ 5 138 (61.9) 2 (1–6)
6–10 39 (17.5) 3 (1–9)
≥ 11 25 (11.2) 4 (2–15)*
Entire life 21 (9.4) 4 (1–7)
Education
≤ 6th grade 88 (39.5) 3 (1–6)
7–12 grade 85 (38.1) 3 (1–6)
Completed high school 50 (22.4) 4 (1–9)
Prior pregnancy
No 92 (41.3) 3 (1–7)
Yes 131 (58.7) 3 (1–7)
Trying to get pregnant
No 116 (52.0) 3 (1–6.5)
Yes 107 (48.0) 3 (1–7)
More than 12 months to become pregnant
No 189 (84.8) 2 (1–4)
Yes 36 (15.3) 25 (15–39)*
Menstrual cycles
Regular 175 (78.5) 2 (1–6)
Irregular 48 (21.5) 5 (2–14)*
Hormonal contraceptive use in year before pregnancy
No 149 (66.8) 3 (1–9)*
Yes 74 (33.2) 3 (1–5)
Breast-fed in 2 months before pregnancy
No 213 (95.5) 3 (1–6)
Yes 10 (4.5) 9 (4–43)*
History of gynecologic conditions
No 178 (79.8) 3 (1–6)
Yes 45 (20.2) 4 (1–9)
Smokedb
No 199 (89.6) 3 (1–6)
Yes 23 (10.4) 4 (1–9)
Caffeine consumptionb
No 30 (13.5) 1.5 (1–5)
Yes 193 (86.6) 3 (1–7)
Mother worked in agricultureb
No 121 (54.3) 3 (1–6)
Yes 102 (45.7) 3 (1–8)*
Lived ≤ 200 feet of agricultural fieldb
No 187 (83.9) 3 (1–6)
Yes 36 (16.1) 4 (1–16.5)*
Pesticides applied in homeb
No 202 (90.6) 3 (1–6)
Yes 21 (9.4) 5 (3–12)*
aAge at beginning of time-to-pregnancy period. bDuring the time-to-pregnancy period. *Associated with longer time to 
pregnancy in univariate proportional hazards models (p < 0.05).PBDEs and fecundability
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gas   chromatography/isotope-dilution high-
  resolution mass spectrometry (Sjödin et al. 
2004). Serum was analyzed for 10 PBDE con-
geners: BDEs 17, 28, 47, 66, 85, 99, 100, 
153, 154, and 183. Quality assurance and 
control procedures included the use of blanks 
and spiked samples in each sample batch 
(Sjödin et al. 2004). Maternal serum was ana-
lyzed for total cholesterol and triglyceride lev-
els using standard enzymatic methods (Roche 
Chemicals, Indianapolis, IN) (Phillips et al. 
1989). PBDE concentrations were reported 
both as wet weight (picograms per unit serum) 
and lipid adjusted (nanograms per gram of 
lipids). The limits of detection (LODs) for 
PBDE analyses were between 0.2 and 0.7 ng/g 
lipids for all congeners, except for BDE-47, 
which ranged from 0.8 to 2.6 ng/g lipids.
Statistical analysis. PBDE concentrations 
below the LOD but for which a signal was 
detected were coded with the concentration 
obtained. Data below the LOD for which no 
signal was detected were coded as the low-
est concentration obtained for that congener 
divided by the square root of 2 (Hornung and 
Reed 1990). Statistical analysis was limited to 
congeners that were detected in > 75% of the 
population (BDEs 47, 99, 100, and 153). The 
detection frequencies for these target analytes 
were high, ranging from 99.6% (BDE-47) to 
97.3% (BDE-100). A sum PBDE variable was 
created by adding the four highly detected con-
geners (both as nanograms per gram of lipids 
and on the molar scale); the variable summed 
by weight is presented unless otherwise noted.
Cox proportional hazards models modi-
fied for discrete time data were used to esti-
mate fecundability odds ratios (fORs) for the 
association between PBDE congeners and 
time to pregnancy (Baird 1988). The fOR 
estimates the odds of achieving pregnancy in 
any given month, conditional on not having 
become pregnant in a previous cycle. Thus, 
fORs < 1 indicate longer time to pregnancy 
and decreased fecundability. The unit of analy-
sis was months, with pregnancies occurring 
in the first cycle coded as 1 month. Time to 
pregnancy was censored at 13 months to lessen 
the influence of outliers and because couples 
receiving fertility treatment generally seek it 
after attempting to conceive for > 12 months. 
Separate models were run for each PBDE con-
gener. Statistical analyses were performed using 
STATA 10 (StataCorp, College Station, TX).
Covariates were included in the adjusted 
Cox models if they were independently asso-
ciated with both time to pregnancy and the 
summed PBDE variable or if their exclusion 
from the model changed the coefficient for 
the sum of PBDEs by ≥ 10%. Table 1 lists 
maternal factors tested as covariates; paternal 
age, smoking, and work in agriculture were 
also considered as covariates. Covariates 
retained in the final models were maternal age 
and indicator variables for years of residence 
in the United States, history of gynecologic 
conditions, hormonal contraceptive use in 
the year before conception, breast-feeding in 
the 2 months before conception, and caffeine 
consumption in the 3 months before preg-
nancy. Covariates were categorized as shown 
in Table 1 unless otherwise specified. We have 
previously shown that markers of maternal pes-
ticide exposure are associated with longer time 
to pregnancy (Harley et al. 2008); thus, three 
variables to assess pesticide exposure during 
the prepregnancy period were also retained 
in the final model: work in agriculture, home 
pesticide use, and residence within 200 feet of 
an agricultural field. Because menstrual cycle 
irregularity and history of gynecologic condi-
tions might be on the causal pathway, final 
models were tested with and without these 
variables. Frequency of intercourse was tested 
as a covariate, but its inclusion did not change 
the results.
After final models were identified, sensi-
tivity analyses were conducted to determine 
whether the relation of PBDEs and fecund-
ability changed when a) the population was 
limited to women actively trying to become 
pregnant (n = 107) or to primiparous women 
(n = 92), b) the population was expanded to 
include women who were using contraception 
at the time of pregnancy (i.e., contraceptive 
failures) (n = 317), or c) time to pregnancy was 
censored at 7, 10, or 15 months rather than 
13 months (Joffe et al. 2005). Results of these 
models were compared with the main models 
to assess consistency of results under these dif-
fering conditions. Additionally, because using 
lipid-adjusted exposure measures can result 
in bias (Schisterman et al. 2005), we also ran 
all models using wet-weight PBDE concen-
trations (picograms per gram of serum) and 
including lipids as a covariate in the model. 
Because results were similar regardless of how 
lipids were considered, results using the lipid-
adjusted PBDE values (nanograms per gram 
of lipids) are reported.
Because altered menstrual cycle function 
could be a mechanism by which PBDEs affect 
fecundability, we also examined the association 
of maternal PBDE levels with menstrual cycle 
characteristics. The association of PBDE levels 
with irregular menstrual cycles was examined 
using logistic regression. Among women with 
regular menstrual cycles, we examined the 
association of PBDE levels with cycle length as 
a continuous variable using linear regression. 
This analysis was limited to women who 
reported that they had not used hormonal 
contraception in the previous year (n = 191), 
because this could affect menstrual cycle char-
acteristics. p-Values for significance < 0.05.
Results
Participants in the study were mostly young, 
Mexican-immigrant women (Table 1). 
Educational attainment was low, with 78% 
of participants having less than a high school 
education. Most participants lived near agri-
cultural fields, and almost half worked in agri-
culture before pregnancy. Fewer than half of 
the women were actively trying to get preg-
nant at the time of conception; an additional 
37% were not concerned about whether they 
became pregnant, and 15% were trying not 
to become pregnant. Median time to preg-
nancy was 3 months (range, 1–180 months). 
Fifteen percent of participants took longer 
than 12 months to conceive.
Factors associated with longer time to 
pregnancy in this population included irreg-
ular menstrual cycle, breast-feeding within 
2 months of conception, and living in the 
United States for ≥ 11 years (compared with 
recent immigrants living in the United States 
for ≤ 5 years). Women working in agriculture, 
living within 200 feet of a field, or using pes-
ticides in their homes also had longer time to 
pregnancy. Women who were using hormonal 
contraception in the year before pregnancy 
had shorter time to pregnancy.
Table 2 shows PBDE levels in maternal 
blood during pregnancy. More than 97% of 
women had detectable levels of BDEs 47, 
99, 100, and 153, and these four congeners 
were highly correlated (r = 0.77–0.95). These 
high detection frequencies were similar to 
those observed for Mexican-American women 
participating in the 2003–2004 NHANES 
survey (Sjödin et al. 2008). Analyses for 
NHANES were conducted by the same labo-
ratory and had similar LODs as in this study. 
Geometric mean concentrations of BDEs 47, 
99, 100, and 153 in our sample were slightly 
lower than for 18- to 40-year-old Mexican-
American women in NHANES, possibly 
because a higher percentage of women in our 
sample than in the NHANES population 
were recent immigrants to the United States. 
The strongest predictor of PBDE levels in 
our population was years of residence in the 
United States, with higher PBDE concentra-
tions seen among women who had lived in the 
Table 2. Lipid-adjusted PBDE concentrations (ng/g lipid) in serum of pregnant women: CHAMACOS study, 
1999–2000 (n = 223).
PBDE congener Percent detect Geometric mean (95% CI) IQR
BDE-47 99.6 14.9 (12.9–17.2) 7.4–25.2
BDE-99 99.6 4.4 (3.9–5.1) 2.2–64
BDE-100 97.3 2.8 (2.4–3.2) 1.5–4.0
BDE-153 97.8 2.5 (2.2–2.8) 1.2–3.6Harley et al.
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United States longer (Bradman et al. 2008). 
We detected all 10 congeners analyzed in this 
population of pregnant Californians; specifi-
cally, we detected BDE-17 in 1%, BDE-28 
in 46%, BDE-66 in 15%, BDE-85 in 45%, 
BDE-154 in 40%, and BDE-183 in 31% of 
women. Because we detected these congeners 
in < 75% of women, we did not include them 
in the time-to-pregnancy analysis.
We ran separate Cox models for each conge-
ner. Table 3 shows the unadjusted and adjusted 
fORs associated with increasing concentrations 
of the four dominant PBDE congeners, indi-
vidually and summed. After controlling for 
confounders, each 10-fold increase in the con-
centration of BDE-100 and BDE-153 was asso-
ciated with a 40% decrease [fOR = 0.6; 95% 
confidence interval (CI), 0.4–0.9; p < 0.01] and 
50% decrease (fOR = 0.5; 95% CI, 0.3–0.8; 
p < 0.01), respectively, in the odds of achieving 
pregnancy in each month. BDEs 47 and 99 
were also associated with 20–30% lower odds of 
pregnancy, but these findings were of borderline 
statistical significance (p = 0.07 and p = 0.11, 
respectively). When concentrations of all four 
congeners were summed, a 10-fold increase 
in the sum PBDEs was associated with 30% 
decreased odds of pregnancy each month (fOR 
= 0.7; 95% CI, 0.5–1.0; p = 0.04).
When the population was limited to 
women actively trying to become pregnant 
(n = 107), all four PBDE congeners were asso-
ciated with reduced fecundability at p < 0.05, 
and the magnitude of the effect was greater 
than in the entire population (Table 3).
In additional sensitivity analyses (i.e., limit-
ing the population to primiparas, expanding 
the population to include women experienc-
ing contraceptive failure, or changing the right 
censoring of the time-to-pregnancy variable), 
results were similar to those reported in Table 3. 
We found statistically significant reductions in 
fORs for BDE-100 and BDE-153 in almost all 
of the sensitivity analyses, whereas the fORs for 
BDE-47 and BDE-99 were reduced but of bor-
derline statistical significance. Figure 1 shows 
sensitivity analyses for BDE-153 [for the other 
three congeners, see Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0901450)]. Results 
were also similar when PBDE congeners were 
summed on a molar basis and when PBDEs 
were expressed on a wet-weight basis (data not 
shown). We found no interaction of pesticide 
exposure and PBDEs. 
Irregular menstrual cycles did not appear 
to be the mechanism by which PBDEs were 
affecting fertility. PBDE concentrations 
were not associated with irregular menstrual 
cycles in this population. Among women 
with regular cycles, higher PBDE levels were 
associated with shorter cycle length, but this 
finding was not statistically significant [see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0901450)]. When we included irregular 
menstrual cycles as a covariate in the mod-
els, the association of PBDEs and time to 
pregnancy remained similar and was actually 
slightly stronger than when we did not control 
for this variable, suggesting that irregular men-
strual cycles was not on the causal pathway.
Discussion
Similar to other studies, we found that the 
PBDE congeners present in the highest concen-
tration were BDEs 47, 99, 100, and 153. We 
detected these congeners, components of the 
penta-BDE mixture, in > 95% of women. We 
found that increased concentrations of PBDEs 
in serum were associated with longer time to 
pregnancy in a population of low-income, preg-
nant Latinas in California. All four congeners, 
as well as the sum of the four congeners, were 
associated with reduced   fecundability.
This study provides the first evidence that 
PBDEs may affect human fertility. Infertility 
affects an estimated 2.1 million couples in the 
United States (Chandra et al. 2002), causing 
considerable emotional strain and often result-
ing in medical intervention with substantial 
financial costs to prospective parents and soci-
ety. Because exposure to PBDEs is ubiquitous 
in industrialized nations, even small decreases 
in fecundability may have wide-reaching pub-
lic health impacts. Although penta- and octa-
BDE are no longer in widespread use, and 
legislation to restrict the use of deca-BDE is 
being considered in many countries and states, 
exposure to PBDEs is likely to continue for 
many years as existing furniture, carpet pad-
ding, electronics, and other consumer products 
containing these flame retardant chemicals 
age and degrade. Analysis of house dust from 
homes of low-income children in our study 
region has found the highest reported levels of 
PBDEs to date (Quiros L, unpublished obser-
vations), suggesting that the next generation of 
Californians may be more extensively exposed.
The mechanisms by which PBDEs might 
affect fecundability are unclear, although 
one possibility is through disruptions of the 
Figure 1. Adjusted fOR and 95% CIs for association of BDE-153 in maternal serum with time to pregnancy, 
according to various sensitivity analyses. (Time to pregnancy is censored at 13 months unless otherwise 
specified.) Models: a, main population (n = 223); b, main plus all pregnancies resulting from contraceptive 
failure (time to pregnancy = 0; n = 317); c, main plus contraceptive failure with irregular contraceptive use 
(time to pregnancy = duration of irregular use/2; n = 249); d, main plus contraceptive failure with regular 
contraception use (time to pregnancy = 0; n = 291); e, main plus all contraceptive failure (time to pregnancy 
= 0 or duration/2; n = 317); f, main, censored at 7 months (n = 223); g, main, censored at 10 months (n = 223); 
h, main, censored at 15 months (n = 223); i, limited to primiparas (n = 92); j, limited to those actively trying 
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Table 3. Association of log10-transformed mater-
nal PBDE concentration (ng/g lipid) with time to 





All women (n = 223)
BDE-47 0.69 (0.48–1.01) 0.73 (0.51–1.04)
BDE-99 0.74 (0.51–1.06) 0.76 (0.54–1.06)
BDE-100 0.59 (0.39–0.87)* 0.61 (0.42–0.89)*
BDE-153 0.53 (0.34–0.82)* 0.52 (0.33–0.81)*
Sum PBDE 0.66 (0.44–0.97)* 0.68 (0.47–0.98)*
Women trying to become pregnant (n = 107)
BDE-47 0.60 (0.37–0.97)* 0.51 (0.31–0.84)*
BDE-99 0.61 (0.38–0.98)* 0.58 (0.37–0.89)*
BDE-100 0.54 (0.32–0.90)* 0.42 (0.23–0.78)*
BDE-153 0.54 (0.31–0.93)* 0.34 (0.16–0.69)*
Sum PBDE 0.56 (0.34–0.94)* 0.45 (0.25–0.78)*
aSeparate models for each congener. bAdjusted for 
mother’s age, years of residence in the Unites States, 
history of gynecologic conditions, hormonal contracep-
tive use in previous year, breast-feeding in previous 
2 months, caffeine consumption, and pesticide exposure 
in before pregnancy (work in agriculture, home pesticide 
use, and residence within 200 feet of an agricultural 
field). *p < 0.05.PBDEs and fecundability
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hypothalamic–pituitary–thyroid axis. Several 
animal studies have shown that PBDE expo-
sure is associated with reduced free and total 
thyroxine (T4) (Darnerud et al. 2007; Fernie 
et al. 2005; Hallgren et al. 2001; Kuriyama 
et al. 2007; Lema et al. 2008; Zhou et al. 
2001, 2002). In utero PBDE exposure in 
female rats has been associated with repro-
ductive effects, including decreased ovarian 
weight and follicle number (Lilienthal et al. 
2006; Talsness et al. 2008), that are similar 
to effects seen with induced hypothyroidism 
(Dijkstra et al. 1996).
However, although animal studies suggest 
a link between PBDEs and hypothyroidism, 
PBDE exposure is associated with subclinical 
hyperthyroidism in this population (Chevrier 
J, Harley KG, Bradman A, Gharbi M, Sjodin 
A, Eskenazi B, unpublished observations) 
and with increased T4 or decreased thyroid-
stimulating hormone in other epidemiologic 
studies (Hagmar et al. 2001; Meeker et al. 
2009; Turyk et al. 2008). Both high and low 
thyroid hormone levels can disturb normal 
menstrual patterns, and treatment to restore 
thyroid hormone homeostasis often improves 
fertility (Cramer et al. 2003; Poppe and 
Velkeniers 2004).
A second possible mechanism by which 
PBDE exposure may be affecting fertility is 
via the hypothalamus–pituitary–gonadal axis. 
In in vitro estrogen receptor binding assays, 
lower brominated PBDEs, including BDEs 
28, 47, and 100, exhibit estrogenic activity, 
whereas higher brominated compounds, such 
as BDE-153 and BDE-190, show antiestro-
genic properties (Hamers et al. 2006; Meerts 
et al. 2001). Antiandrogenic activity and pro-
gesterone receptor antagonist activity has been 
observed for some congeners (Hamers et al. 
2006). In animal studies, prenatal exposure 
to PBDEs has been associated with delayed 
puberty in females (Lilienthal et al. 2006; 
Stoker et al. 2004) and higher fetal resorption 
rates (Talsness et al. 2005).
The findings of this study are limited 
to the four main congeners, BDEs 47, 99, 
100, and 153, that we detected in almost all 
women. The levels of these four congeners 
were highly correlated (r = 0.77–0.95), restrict-
ing our ability to distinguish whether one par-
ticular congener is exerting a stronger effect. 
Additionally, because of analytical constraints, 
we were unable to measure BDE-209.
An additional limitation of this study is that 
we measured PBDE levels only in women and 
not in their partners. Although we examined 
paternal factors such as age, smoking, and agri-
cultural work, we were unable to examine the 
role of male PBDE exposure in this analysis.
We conducted this study in a farmworker 
community, and findings may not be gener-
alizable to other populations. We previously 
found that potential exposure to pesticides, 
as assessed by occupational and residential 
patterns, was associated with reduced fecund-
ability in this population (Harley et al. 2008). 
However, all models controlled for these vari-
ables, and current pesticide exposure was not 
associated with PBDE levels. Further, we did 
not find any associations of time to pregnancy 
with maternal concentrations of persistent 
organochlorine pesticides, such as dichlorodi-
phenyltrichloroethane (DDT), or polychlori-
nated biphenyls (PCBs).
Time-to-pregnancy studies may be pro-
spective, following a group of women trying 
to become pregnant, or retrospective, like the 
present study. By design, this study was lim-
ited to women who were already pregnant; 
thus, infertile and subfertile women were 
underrepresented in the sample. However, if 
PBDEs are associated with decreased fecund-
ability, including only the most fecund women 
likely would underestimate the effect, biasing 
the findings toward the null.
An advantage of our study design was 
that it included both women who were try-
ing to conceive and those who were not. 
Approximately 30% of all live births in the 
United States are unplanned (Finer and 
Henshaw 2006). Thus, prospective studies 
that are limited to women who are trying to 
conceive may underrepresent the most fertile 
women and may overrepresent highly moti-
vated couples, making them susceptible to 
other selection biases.
An additional advantage of this study is 
that, although it was retrospective, interviews 
occurred near the beginning of the pregnancy, 
ensuring a short recall time for time-to-preg-
nancy information. A recent validation study 
found that women exhibit poor recall of time 
to pregnancy (Cooney et al. 2009), although 
the recall period of 10 years in that study was 
much longer than for our study. Validation 
studies have also demonstrated poor self-report 
of menstrual cycle characteristics (Jukic et al. 
2008; Small et al. 2007), which may affect 
the interpretation of these results. We meas-
ured PBDE concentrations during pregnancy. 
Because these PBDE congeners are persistent, 
concentrations in blood collected during preg-
nancy likely are a good representation of levels 
during the time-to-pregnancy period.
This study is the first to report that higher 
PBDE concentrations in women’s blood 
are associated with significantly longer time 
to pregnancy, and this finding needs to be 
replicated in other populations. The study 
population of predominantly Mexican immi-
grants living in an agricultural community is 
a distinctive group, and findings may not be 
generalizable to all women. The relationship 
among PBDE exposure, length of time in the 
United States, and fertility is somewhat com-
plex. Although we controlled for both time in 
the United States and pesticide exposure, this 
study should be replicated in a population 
that is not subject to these factors. If con-
firmed, this finding would have strong impli-
cations to women trying to conceive given 
that exposure to PBDEs is nearly universal in 
the United States and many other countries.
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